@fit2fat2fit's enclomiphene testosterone claims, fact-checked
Quick answer
The creator reported a pre-treatment free testosterone of 9.6 (units unspecified) alongside a total testosterone of 458 ng/dL, and a post-treatment free testosterone of 213, citing management through a telehealth platform. If the units are pg/mL, the baseline would fall significantly below standard reference ranges, and the post-treatment value would be within normal limits, consistent with expected TRT outcomes. Free testosterone measurement accuracy depends heavily on the assay method used, and this context was not addressed in the video.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @fit2fat2fit actually say?
The creator claims his free testosterone started at "9.6" and is now "213," framing the original number as alarmingly low. He also notes his total testosterone was 458, which he puts in quotes as "normal." The implication is that total testosterone numbers can be deceptive, and that free testosterone tells a more urgent story. That framing is actually worth taking seriously.
To be precise about what was said: "My free testosterone...was 9.6. Now it's in the green at 213." He does not specify units, which matters a lot here. Free testosterone is typically reported in pg/mL or pmol/L depending on the lab, and the reference ranges are wildly different between the two. That missing detail is not a small thing when you're using numbers to make a clinical point on social media.
Does the science back this up?
The broader point, that total testosterone is an incomplete picture, is supported by research. Free testosterone, the fraction not bound to sex hormone-binding globulin (SHBG) or albumin, is what's actually bioavailable to tissues. A man with a total testosterone of 458 ng/dL but high SHBG can have free testosterone well below normal range, and symptoms to match.
Rosner et al. (2007, Journal of Clinical Endocrinology and Metabolism) argued that free testosterone measurement provides clinical information beyond total testosterone, particularly in men with conditions affecting SHBG. The Endocrine Society's clinical practice guidelines acknowledge that some symptomatic patients with normal total testosterone but low free testosterone may benefit from treatment. A 9.6 pg/mL free testosterone reading in a symptomatic adult male would fall below most lab reference ranges, which typically bottom out around 35-155 pg/mL. If his number was in pg/mL, that is genuinely low. The post-treatment value of 213 pg/mL would sit in the mid-to-upper normal range for most labs.
What did they get wrong (or right)?
They got the underlying clinical concept right. Free testosterone matters, and a total in the "normal" range does not rule out functional hypogonadism. That's legitimate and underreported in general health content.
What's missing is units and context. Without knowing the assay used, 9.6 could mean very different things. The gold standard for free testosterone measurement is equilibrium dialysis, but most commercial labs use calculated free testosterone or analog immunoassay methods, which have known accuracy limitations. Vermeulen et al. (1999, Journal of Clinical Endocrinology and Metabolism) showed that analog immunoassay free testosterone measurements can be unreliable, particularly at low concentrations. So when the creator treats 9.6 as a precise, alarming number, the measurement method matters enormously. He doesn't address that, and neither do most TRT content creators.
The jump to 213 after TRT is plausible and consistent with expected outcomes. That part checks out.
What should you actually know?
Free testosterone testing is genuinely useful but also genuinely messy. The number your lab prints means little without knowing the method behind it. If your doctor or telehealth provider is making treatment decisions based on a calculated or immunoassay free testosterone without considering symptoms and clinical context, that's worth asking about.
TRT can meaningfully increase free testosterone, and symptom improvement is real for many men with documented low levels. But the decision to start TRT involves weighing real risks, including effects on fertility, hematocrit, cardiovascular risk, and endogenous testosterone suppression. Bhasin et al. (2010, New England Journal of Medicine) found increased cardiovascular events in older men on testosterone therapy, a finding that continues to shape clinical caution even if later data have been more mixed.
One creator's before-and-after is not a clinical trial. His experience may be genuine. It is not a template for your own lab results.
- Free testosterone reference ranges vary by lab and method. Always ask which assay was used.
- A "normal" total testosterone does not rule out symptomatic low free testosterone.
- TRT is a regulated medical decision, not a wellness upgrade. It requires ongoing monitoring.
- Compounded testosterone products are not equivalent to brand-name formulations. Do not assume interchangeability.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @fit2fat2fit's enclomiphene testosterone claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@fit2fat2fit's enclomiphene testosterone claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator reported a pre-treatment free testosterone of 9.
FormBlends verdict
The creator reported a pre-treatment free testosterone of 9.6 (units unspecified) alongside a total testosterone of 458 ng/dL, and a post-treatment free testosterone of 213, citing management through a telehealth platform. If the units are pg/mL, the baseline would fall significantly below standard reference ranges, and the post-treatment value would be within normal limits, consistent with expected TRT outcomes. Free testosterone measurement accuracy depends heavily on the assay method used, and this context was not addressed in the video.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator reported a pre-treatment free testosterone of 9.6 (units unspecified) alongside a total testosterone of 458 ng/dL, and a post-treatment free testosterone of 213, citing management through a telehealth platform. If the units are pg/mL, the baseline would fall significantly below standard reference ranges, and the post-treatment value would be within normal limits, consistent with expected TRT outcomes. Free testosterone measurement accuracy depends heavily on the assay method used, and this context was not addressed in the video.
- Free testosterone reference ranges differ by lab and method. A value of 9.6 in pg/mL is below standard male ranges (roughly 35-155 pg/mL), but the assay used determines how much to trust that number.
- Vermeulen et al. (1999, JCEM) showed analog immunoassay free testosterone measurements are often inaccurate, especially at low concentrations. Equilibrium dialysis is the gold standard most commercial labs do not use.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Free testosterone reference ranges differ by lab and method. A value of 9.6 in pg/mL is below standard male ranges (roughly 35-155 pg/mL), but the assay used determines how much to trust that number.
- Vermeulen et al. (1999, JCEM) showed analog immunoassay free testosterone measurements are often inaccurate, especially at low concentrations. Equilibrium dialysis is the gold standard most commercial labs do not use.
- A total testosterone in the 'normal' range (typically 300-1000 ng/dL) does not rule out symptomatic hypogonadism if SHBG is elevated and free testosterone is suppressed.
- TRT can increase free testosterone into normal range. That is an expected and documented outcome, not a unique or surprising result. It does not mean TRT is low-risk or appropriate for everyone.
- Bhasin et al. (2010, NEJM) found increased cardiovascular adverse events in older men on testosterone therapy. Risk-benefit assessment requires individualized clinical evaluation, not lab numbers alone.
- Compounded testosterone is not equivalent to FDA-approved branded formulations. Bioavailability, purity, and dosing consistency can vary. These are not interchangeable products.
- One person's before-and-after is not clinical evidence. Symptom improvement is real for many men on TRT, but self-reported outcomes from social media are not a substitute for a monitored clinical workup.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Drew Manning · Instagram creator
22.4K views on this video
I’ve suffered with Low Testosterone ever since I started testing it back in 2011. I’ve always been in the 300-500 total testosterone range for most of my adult life. When I started working with @ge
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Drew Manning, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.